APA (7th ed.) Citation

M, O., N, O., T, Y., Y, H., K, S., A, E., . . . S, Y. (2022). Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease. Internal medicine (Tokyo, Japan), 61(4), 585. https://doi.org/10.2169/internalmedicine.7971-21

Chicago Style (17th ed.) Citation

M, Ohgushi, Ogo N, Yanagihara T, Harada Y, Sumida K, Egashira A, Asoh T, Maeyama T, and Yoshizawa S. "Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease." Internal Medicine (Tokyo, Japan) 61, no. 4 (2022): 585. https://doi.org/10.2169/internalmedicine.7971-21.

MLA (9th ed.) Citation

M, Ohgushi, et al. "Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease." Internal Medicine (Tokyo, Japan), vol. 61, no. 4, 2022, p. 585, https://doi.org/10.2169/internalmedicine.7971-21.